Barker Brettell has an expert Biotechnology team renowned for its deep sector knowledge and client-centric approach to protecting biotechnological inventions.
Comprising highly experienced attorneys with advanced degrees in molecular biology, biochemistry, genetics, immunology, and the medical sciences, the team’s collaborative approach, technical insight, and in-depth understanding of global patent systems make them a trusted port of call for strategic advice tailored to innovators operating at the forefront of research.
From early-stage research through to commercialisation, the team guides clients through complex patent landscapes, ensuring robust protection for innovations including antibodies and biologics (such as CAR-T therapies), cell and gene therapies, diagnostic and personalised medicines, nucleic acids, peptides, proteins, and vaccines. The team is also able to advise on other aspects such as sequence listings and biological deposits.
To find out more, please contact our Head of Biotechnology, Dr Jennifer Atkinson
< Back to Medical
